FDA declines to approve pre-filled syringe version of Regeneron's Eylea

Regeneron Pharmaceuticals Inc said on Thursday the U.S. Food and Drug Administration declined to approve a pre-filled syringe version of its blockbuster eye drug Eylea, and has sought additional information regarding its manufacturing and supply processes.

from Reuters: Health News https://ift.tt/2yvPnx2